Insights into the Relationship between Periodontitis and Systemic Sclerosis Based on the New Periodontitis Classification (2018): A Cross-Sectional Study
Authors:
- Andreea CiureaACAndreea Ciurea
- Alina StanomirASAlina Stanomir
- Petra ȘurlinPȘPetra Șurlin
- Iulia Cristina MicuIMIulia Cristina Micu
- Cristina PamfilCPCristina Pamfil
- Daniel Corneliu LeucuțaDLDaniel Corneliu Leucuța
- Simona RednicSimona Rednic
- Giulio RasperiniGRGiulio Rasperini
- Andrada SoancăAndrada Soancă
- Adrian Bogdan ȚiguAdrian Bogdan Țigu
- Alexandra RomanAlexandra Roman
- Andrei PicoșAPAndrei Picoș
Open Access
- 4 March 2024
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 14 (5) , 540
Abstract
(1) Background: This study aimed to assess the periodontitis burden in systemic sclerosis patients and the possible association between them, and the degree to which some potential risk factors and two potential diagnostic biomarkers may account for this association. (2) Methods: This cross-sectional study included a test group (systemic sclerosis patients) and a control group (non-systemic sclerosis patients). Both groups benefited from medical, periodontal examination and saliva sampling to determine the salivary flow rate and two inflammatory biomarkers (calprotectin, psoriasin). A systemic sclerosis severity scale was established. (3) Results: In the studied groups, comparable periodontitis rates of 88.68% and 85.85%, respectively, were identified. There were no significant differences in the severity of periodontitis among different systemic sclerosis severity, or in the positivity for anti-centromere and anti-SCL70 antibodies. Musculoskeletal lesions were significantly more common in stage III/IV periodontitis (n = 33, 86.84%) than in those in stage I/II (n = 1, 100%, and n = 3, 37.5%, respectively) (p = 0.007). Comparable levels of the inflammatory mediators were displayed by the two groups. There were no significant differences in calprotectin and psoriasin levels between diffuse and limited forms of systemic sclerosis. (4) Conclusions: Within the limitations of the current study, no associations between systemic sclerosis and periodontitis, or between their risk factors, could be proven.Keywords
Funding Information
- Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania (1033/61, 35191)
This publication has 56 references indexed in Scilit:
- Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine SclerodermaJAMA Dermatology, 2023
- Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19Cell, 2020
- Relationship between preterm birth and post-partum periodontal maternal status: a hospital-based Romanian studyArchives of Gynecology and Obstetrics, 2020
- Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium: Consensus report of workgroup 1 of the 2017 World Workshop on the Classification of Periodontal and Peri‐Implant Diseases and ConditionsJournal of Periodontology, 2018
- Risk association between scleroderma disease characteristics, periodontitis, and tooth lossClinical Rheumatology, 2017
- Advanced glycation end‐products and Porphyromonas gingivalis lipopolysaccharide increase calprotectin expression in human gingival epithelial cellsJournal of Cellular Biochemistry, 2017
- Oral health of Chinese people with systemic sclerosisClinical Oral Investigations, 2010
- Collection, Storage, and Processing of Saliva Samples for Downstream Molecular Applications2010
- S100A8/S100A9 and their association with cartilage and boneJournal of Molecular Histology, 2007
- Analysis of the oral manifestations of systemic sclerosis (scleroderma)Oral Surgery, Oral Medicine, Oral Pathology, 1988